Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS LTD

Security class unavailable · CUSIP: G5269C101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,965,299
Percent of class
8.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-021288
Form type
SC 13G/A
Filer
Kiniksa Pharmaceuticals International, plc
CIK
CIK 1730430
Filed
Feb 13, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub